Plus, rheumatology drug news, safety updates
Search results for: Janus kinase inhibitors
ACR 2013 State-of-the-Art Clinical Symposium: What’s Next in Therapy for Osteoarthritis, Rheumatoid Arthritis, and Lupus?
Experts highlight treatment advances and challenges ahead in OA, RA, and systemic lupus erythematosus (SLE)
Panel Addresses Drug Safety Issues in Rheumatology Products
Black box warnings, TNF inhibitors, and tofacitinib discussed
Rheumatology Drug Updates
Information on new approvals and medication safety rheumatologists need to know
Drug Updates: Citalopram hydrobromide, Statins, and More
Information on new approvals and medication safety
ACR/ARHP Annual Scientific Meeting Plenary Highlights Targets and Treatments for Several Diseases
Promising therapeutic targets for rheumatic diseases were the focus of a plenary session here at the ACR/ARHP 2011 Annual Scientific Meeting in November. Presenters discussed discoveries and treatments for systemic sclerosis, rheumatoid arthritis, vasculitis, and Behçet’s disease.
Information on New Drug Approvals and Medication Safety
Rheumatology-related drug safety, approvals, and what’s in the pipeline.
Opening a New Therapeutic Window for Rheumatoid Arthritis
New targets in rheumatoid arthritis: SYK, JAK, BTK
Drug Updates
Information on New Approvals and Medication Safety
- « Previous Page
- 1
- …
- 14
- 15
- 16